Cookie Statement

This site uses cookies to store information on your computer. Some are essential to make our site work; others help us improve the user experience. By using the site, you consent to the placement of these cookies. You may at any time change the settings regarding cookies. Read our privacy statement to learn more.

Highlighted are countries of origin for publications demonstrating the successful use of LigaSure™ technology in clinical settings across all types of hysterectomy.

Back

Extensive Global Use

Back

Broad Application

LigaSure™ devices have been used in a range of procedures, including abdominal29, radical abdominal13, total laparoscopic27, laparoscopic supracervical30, laparoscopically-assisted vaginal2 and vaginal31 hysterectomy.

Back

Decreased Operative Time

LigaSure™ devices have been shown to significantly reduce the time of hysterectomy compared to suture ligation2,3,13,16,31,32 and in comparison to other energy devices*, has shown similar25,30 and significantly reduced operative time.33

Back

Low Intraoperative Blood Loss

The use of LigaSure™ devices has been shown to decrease the volume of blood lost during hysterectomy compared to suture ligation.2,3,31 Compared to other energy devices*, LigaSure™ technology has achieved similar25,30 and significantly lower blood loss.33

Back

Low Post-Operative Pain

The use of LigaSure™ devices compared to suture ligation has been shown to result in significantly lower pain in the days after surgery3,16,31 and in fewer patients experiencing pain after the first post-operative week.2

Back

Low Complication Rates

LigaSure™ technology has been demonstrated to numerically reduce the risks of infection significantly2 and non-significantly2,29 after hysterectomy. LigaSure™ devices do not alter the risk of bladder injuries2,16,29, or overall risk of general post-surgical complications2,3,29 associated with hysterectomy when compared to sutue ligation.